MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

Data show minimal risk of stopping DMTs in older MS patients with stable disease. Now, the focus has shifted to understanding ...

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

They are indicated for adults with relapsing forms of MS. In the end, starting and sticking to a DMT—even if you have to ...

It may be sensible for older patients with MS who have prolonged stability to cease disease-modifying therapy, but more data ...

There’s no cure for MS, but treatment can help manage the symptoms and slow the progression of the disease. These treatment options are known as disease-modifying therapies (DMTs). A main DMT ...

The risk of disease activity in going to a less effective DMT was higher in younger adults and those having prior ...

Ozanimod treatment for early relapsing multiple sclerosis helps prevent impaired cognitive functioning during the first year of use.